Emerald Health Therapeutics Strategic Licensee, FlowerPod, Unveils Groundbreaking Dose-Controlled Cannabis Vaping Product, New Brand, and U.S. Launch Plans
Ryan Allway
October 28th, 2021
News
Emerald Patent Licensee Announces Partnership with Leading Cannabis Vaporization Technology Company, Grenco Science
Vancouver, British Columbia–(Newsfile Corp. – October 28, 2021) – Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) (“Emerald”) announces that its partner, FlowerPod LLC, has completed product development related to a new form of cannabis consumption, a first-of-its-kind cannabis vaporizer puck, created a new brand called HUUETM, and established a partnership with Grenco Science, the leader in advanced cannabis vaporization technology, to provide a go-to-market strategy. As announced by Emerald in May, FlowerPod exclusively licensed the use of Emerald intellectual property relating to the cannabis puck concept for all US states, with an option to expand globally (excluding select medical markets including Canada) upon meeting certain milestones. FlowerPod plans to launch HUUETM in Massachusetts in December 2021 with select retailers and will quickly expand into additional states in 2022.
HUUE™’s first-of-its-kind cannabis vaporizer puck, Bounce Back
To view an enhanced version of this image, please visit:
https://orders.newsfilecorp.com/files/3366/101125_84d1c59554636961_001full.jpg
FlowerPod’s intent with its innovative HUUETM plant-based vaporizer pucks is to fill a void in the market with an environmentally-friendly flower consumption format that is portable, user-friendly and provides a consistent dosage with every vaporization experience. HUUE™ bypasses the barriers to entry for new and goal-seeking cannabis users by providing a convenient (fast form factor; no grinding or mess), dose-controlled, and discreet delivery system. It simplifies the cannabis experience by creating five puck varieties catering to prominent social needs, including Productivity, Socialization, Anxiety, Pain and Sleep, with 3 SKUS available at launch – (Un)Wine, GSD, and ROFL.
Based on Emerald’s initial prototype design and development collaboration with Emerald, FlowerPod designed its compact flower pucks for use with Grenco Science’s G Pen Dash dry herb personal vaporizer. Compact and lightweight, the Dash features a glass-glazed stainless steel heating chamber combined with a clean air source and integrated air path for unsurpassed flavor from the HUUE™ experience. FlowerPod is device-agnostic and plans to launch its HUUE™ products with other vaporizer devices in the future.
“We believe this innovation in the dry herb vaping space is extremely overdue and that it will do for cannabis what pods did for the coffee industry, introducing incredible benefits of cannabis in an easy-to-use, clean convenient format,” said FlowerPod Head of Communications & Lead Investor, David Salinas. “The mission with HUUE™ is to introduce an entirely new set of everyday cannabis consumers to the market by simplifying the cannabis vaporization experience. Our partnership with long-standing industry titan Grenco Science will be game-changing for accomplishing that.”
“Grenco Science is excited to partner with this revolutionary brand and bring HUUE™ into our growing portfolio of partners. The HUUE™ pucks will forever change the way people use plant-based vaporizers. We look forward to helping grow HUUE™ into a leading global brand in the industry,” said Chris Folkerts, CEO and founder of Grenco Science.
As part of the license agreement, Emerald provided FlowerPod with a repayable loan of US$350,000. Emerald received 19% equity ownership of FlowerPod and will receive IP license payments.
“It is gratifying to see the maturing development of this product concept from our original ideation, patenting and engineering through to FlowerPod’s manufacturing, elegant branding, and strategic sales and marketing initiatives for HUUE™ that are now coming to fruition to soon launch this unique cannabis product line,” said Riaz Bandali, President and CEO. “Emerald’s focus on science-driven product innovation and intellectual property development provided the right foundation for this development, and we look forward to seeing the results of the HUUE™ product launch.”
About HUUE
HUUE™ Plant-Based Vapes is a new innovation in the cannabis vaporization space, providing the full spectrum benefits of cannabis flower fresh-pressed into a compact and convenient puck. For more information, contact david@huue.co. Visit huue.co.
About Grenco Science
Grenco Science is a leader in engineering advanced cannabis vaporizers, setting new standards in aesthetics, portability, functionality, and user experience. Through proprietary research and development, as well as collaborations with influencers in music, art, and fashion, Grenco Science is transforming the cannabis experience and leading the movement to bring cannabis traditions to the 21st century. Visit gpen.com.
About Emerald Health Therapeutics
Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and product excellence.
Please visit www.emeraldhealth.ca for more information or contact:
Riaz Bandali, Chief Executive Officer
(800) 757 3536 Ext. #5
Emerald Investor Relations
(800) 757 3536 Ext. #5
invest@emeraldhealth.ca
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Note Regarding Forward-Looking Statements: Certain statements made in this press release that are not historical facts are forward-looking statements and are subject to important risks, uncertainties and assumptions, both general and specific, which give rise to the possibility that actual results or events could differ materially from our expectations expressed in or implied by such forward-looking statements. Such statements include: the effects of products developed by FlowerPod; the launch date of products developed by FlowerPod; partnerships with third parties; expansion to other geographical areas; payment of amounts owned to Emerald; and FlowerPod meeting certain milestones.
We cannot guarantee that any forward-looking statement will materialize, and readers are cautioned not to place undue reliance on these forward-looking statements. These forward-looking statements involve risks and uncertainties related to, among other things, changes of law and regulations; changes of government; failure to obtain regulatory approvals or permits; failure to obtain necessary financing; results of product development, production and sale activities; changes in prices and costs of inputs; demand for products; changes in business strategy; as well as the risk factors described in Emerald’s annual information form and other regulatory filings. The forward-looking statements contained in this press release represent our expectations as of the date hereof. Forward-looking statements are presented for the purpose of providing information about management’s current expectations and plans and allowing investors and others to obtain a better understanding of our anticipated operating environment. Readers are cautioned that such information may not be appropriate for other purposes. Emerald undertakes no obligations to update or revise such statements to reflect new circumstances or unanticipated events as they occur, unless required by applicable law.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Technical420 is the premier provider of research and analysis on cannabis stocks. We provide investors with sponsored and non-sponsored information on the volatile and emerging cannabis industry. “Our research is our passion!” Your profit is our reward!
Matt Hawkins is the founder and managing principal of Cresco Capital Partners, LLC (“Cresco”), a private equity firm focused specifically on investing in the legalized cannabis industry. Since its inception in the summer of 2015, Cresco has made 14 investments out of its first fund and is currently raising this fund, Fund II. Prior to the […]
Nabis Holdings is a Canadian investment issuer that invests in high quality cash flowing assets across multiple industries, including real property, securities, cryptocurrency, and all aspects of the U.S. and international cannabis sector.
MagicMed Industries intends to partner with pharmaceutical and other companies to develop psychedelic-derived medicinal and licit consumer goods products.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
